25 Significantly, only a meta-analysis demonstrated the risk reduction in HF hospitalisation
2024 systematic review, Cohen et al
That's hundreds of times more than any patch could realistically deliver through the skin, and berberine's molecular structure isn't ideally suited to transdermal absorption in the first place
Any use for long-term healthspan or lifespan benefits should be guided by a physician who can carefully weigh the risks, monitor possible side effects, and create a plan tailored to your unique health profile
Kushner, MD, notes, People often ask how one medication compares to another when making obesity treatment management decisions this indirect treatment comparison from the ORION study provides important information that can be used during the shared decision-making process. Get the full story here: #Wegovy #Foundayo #GLP1 #Obesity #WeightLossDrugs #IncretinTherapies #PatientAdherence To view or add a comment, sign in Eli Lilly's weight-loss pill wins US approval providing another convenient alternative to weight-loss injections, while putting the company back in direct competition with Danish drugmaker Novo Nordisk for share in the oral obesity treatments market
Theyre not what they claim to be
